Don't Blame the PSA Test for the 'Overtreatment' of Prostate Cancer
Early Detection Pays Off, as the PSA Test is to Men what the Mammogram is to Women
WASHINGTON, July 27 /PRNewswire-USNewswire/ -- A new report published in the July 26 issue of Archives of Internal Medicine claims many men who are diagnosed with prostate cancer undergo aggressive therapy, even when they have low PSA scores and low-risk disease, saying "these results underscore the fact that PSA level, the current biomarker, is not a sufficient basis for treatment decisions."
"When it comes to 'overtreatment,' the PSA test is not to blame – it's what happens next," said Skip Lockwood, ZERO's CEO.
Federal Government Reverses Course, Now Sees Benefit of PSA Testing
NCI Admits its Previous Prostate Cancer Study was 'Contaminated' Following the Release of New Data that Shows PSA Test Saves Lives
WASHINGTON, July 15 /PRNewswire-USNewswire/ -- The nation's leading authority on cancer has thrown out its own study on prostate cancer screening, now saying that PSA testing reduces the prostate cancer death rate by nearly 50 percent.
In its July 13th bulletin, the National Cancer Institute says findings from the Goteborg Randomized Population-Based Prostate Cancer Screening Trial - a study NCI partially funded in Sweden - shows "PSA screening substantially improves cancer-specific survival without the extent of over-diagnosis and overtreatment." The Swedish study showed testing reduces the prostate cancer mo...
American Cancer Society Got it Wrong: Study Confirms Prostate Cancer Test Saves Lives
ZERO Demands ACS Apology to All American Families About Prostate Cancer Testing as New Proof Emerges on the Effectiveness of the PSA Test
WASHINGTON, July 2 /PRNewswire-USNewswire/ -- With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO – The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American Cancer Society, which has long discounted the importance of prostate cancer testing.
"It's time to 'Man Up' and admit they were wrong," said ZERO CEO Skip Lockwood.
|
|
 |
 |
|
Why You Should Consider a Prostate Cancer PSA Test TODAY.
Prostate Cancer kills if allowed to grow. If ever there was a good reason to have a simple blood test, this is it. The Prostate cancer PSA (Prostate Specific Antigen) test is one of the tests given to determine if cancer cells are present in an otherwise healthy prostate. It is a simple blood test to help doctors diagnose and identify the existence of prostate cancer.
New Test May Catch Prostate Cancer Earlier Than Ever Before: Leading PhD and Expert in Molecular Biology and Genetics Weighs in on Recent Study
According to Dr. Shashi Pawar, PhD, director of molecular biology and genetics at Acupath Laboratories in New York, "A new test may catch prostate cancer earlier than ever before. A recent study has uncovered a new, accurate test for prostate cancer diagnosis. Measuring levels of an early prostate specific antigen called EPCA-2 has been found to be a more effective way to detect prostate cancer than the current PSA test, which more often than not produces false-positive or false-negative results."
Comprehensive PSA Test for Most Prevalent Male Cancer
For decades the "gold standard" in testing for prostate cancer - the most prevalent and deadly male cancer - has been the Total PSA screening. Yet, simply measuring the amount of PSA in the bloodstream has its drawbacks. Researchers have discovered a new, more comprehensive way to measure PSA in the bloodstream that can lead to more accurate diagnosis. A newer and more accurate test measures the ratio between "free" PSA and total PSA in the bloodstream to determine how likely it is that a malignant prostate tumor is present.
|
 |
|
